-
Signature
-
Laura Heiman, Attorney-in-fact
-
Issuer symbol
-
MCK
-
Transactions as of
-
12 Oct 2023
-
Net transactions value
-
-$3,380,042
-
Form type
-
4
-
Filing time
-
13 Oct 2023, 17:20:40 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
MCK |
Common Stock |
Options Exercise |
$1,096,079 |
+7,589 |
+11% |
$144.43 |
74,997 |
12 Oct 2023 |
Direct |
F1 |
| transaction |
MCK |
Common Stock |
Sale |
$3,490,940 |
-7,589 |
-10% |
$460.00 |
67,408 |
12 Oct 2023 |
Direct |
F1 |
| transaction |
MCK |
Common Stock |
Options Exercise |
$363,539 |
+2,932 |
+4.3% |
$123.99 |
70,340 |
12 Oct 2023 |
Direct |
F1 |
| transaction |
MCK |
Common Stock |
Sale |
$1,348,720 |
-2,932 |
-4.2% |
$460.00 |
67,408 |
12 Oct 2023 |
Direct |
F1 |
| holding |
MCK |
Common Stock |
|
|
|
|
|
214 |
12 Oct 2023 |
By the McKesson Corporation 401(k) Retirement Savings Plan |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
MCK |
Employee Stock Option (Right-to-buy) |
Options Exercise |
$0 |
-7,589 |
-30% |
$0.000000 |
17,707 |
12 Oct 2023 |
Common Stock |
7,589 |
$144.43 |
Direct |
F2 |
| transaction |
MCK |
Employee Stock Option (Right-to-buy) |
Options Exercise |
$0 |
-2,932 |
-30% |
$0.000000 |
6,840 |
12 Oct 2023 |
Common Stock |
2,932 |
$123.99 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: